187 related articles for article (PubMed ID: 2787049)
1. Osteocalcin and bone remodelling in Paget's disease of bone, primary hyperparathyroidism, hypercalcaemia of malignancy and involutional osteoporosis.
Torres R; de la Piedra C; Rapado A
Scand J Clin Lab Invest; 1989 May; 49(3):279-85. PubMed ID: 2787049
[TBL] [Abstract][Full Text] [Related]
2. Osteocalcin and urinary hydroxyproline/creatinine ratio in the differential diagnosis of primary hyperparathyroidism and hypercalcaemia of malignancy.
de la Piedra C; Toural V; Rapado A
Scand J Clin Lab Invest; 1987 Oct; 47(6):587-92. PubMed ID: 3499657
[TBL] [Abstract][Full Text] [Related]
3. Correlation between serum osteocalcin and 24,25-dihydroxyvitamin D levels in Paget's disease of bone.
Castro-Errecaborde N; de la Piedra C; Rapado A; Alvarez-Arroyo MV; Torres R; Traba ML
J Clin Endocrinol Metab; 1991 Feb; 72(2):462-6. PubMed ID: 1991815
[TBL] [Abstract][Full Text] [Related]
4. [Usefulness of bone remodelling biochemical markers in the diagnosis and follow-up of Paget's bone disease, primary hyperparathyroidism, tumor hypercalcemia, and postmenopausal osteoporosis. II. Bone resorption markers].
de la Piedra Gordo C; Torres Jiménez R
An Med Interna; 1990 Oct; 7(10):534-8. PubMed ID: 2104101
[TBL] [Abstract][Full Text] [Related]
5. Serum bone gamma carboxyglutamic acid-containing protein in primary hyperparathyroidism and in malignant hypercalcemia. Comparison with bone histomorphometry.
Delmas PD; Demiaux B; Malaval L; Chapuy MC; Edouard C; Meunier PJ
J Clin Invest; 1986 Mar; 77(3):985-91. PubMed ID: 3485113
[TBL] [Abstract][Full Text] [Related]
6. [The usefulness of biochemical markers of bone remodelling in the diagnosis and follow-up of Paget's disease of bone, primary hyperparathyroidism, tumoral hypercalcemia and postmenopausal osteoporosis. I. The markers of bone formation].
de la Piedra Gordo C; Torres Jiménez R
An Med Interna; 1990 Sep; 7(9):480-6. PubMed ID: 2103291
[TBL] [Abstract][Full Text] [Related]
7. Non-invasive evaluation of bone formation: measurements of serum alkaline phosphatase, whole body retention of diphosphonate and serum osteocalcin in metabolic bone disorders and thyroid disease.
Hyldstrup L; Clemmensen I; Jensen BA; Transbøl I
Scand J Clin Lab Invest; 1988 Nov; 48(7):611-9. PubMed ID: 3264412
[TBL] [Abstract][Full Text] [Related]
8. Estimation of bone turnover evaluated by 47Ca-kinetics. Efficiency of serum bone gamma-carboxyglutamic acid-containing protein, serum alkaline phosphatase, and urinary hydroxyproline excretion.
Charles P; Poser JW; Mosekilde L; Jensen FT
J Clin Invest; 1985 Dec; 76(6):2254-8. PubMed ID: 3878367
[TBL] [Abstract][Full Text] [Related]
9. Serum bone GLA-protein is not a sensitive marker of bone turnover in Paget's disease of bone.
Delmas PD; Demiaux B; Malaval L; Chapuy MC; Meunier PJ
Calcif Tissue Int; 1986 Jan; 38(1):60-1. PubMed ID: 3079654
[TBL] [Abstract][Full Text] [Related]
10. Clinical usefulness of serum tartrate-resistant acid phosphatase in Paget's disease of bone: correlation with other biochemical markers of bone remodelling.
Torres R; de la Piedra C; Rapado A
Calcif Tissue Int; 1991 Jul; 49(1):14-6. PubMed ID: 1893290
[TBL] [Abstract][Full Text] [Related]
11. [Osteocalcin].
Galli M; Caniggia M
Minerva Med; 1984 Nov; 75(42):2489-501. PubMed ID: 6334818
[TBL] [Abstract][Full Text] [Related]
12. Urinary gamma-carboxyglutamic acid and serum osteocalcin as bone markers: studies in osteoporosis and Paget's disease.
Gundberg CM; Lian JB; Gallop PM; Steinberg JJ
J Clin Endocrinol Metab; 1983 Dec; 57(6):1221-5. PubMed ID: 6605357
[TBL] [Abstract][Full Text] [Related]
13. Parathyroid function in Paget's disease of bone.
Siris ES; Clemens TP; McMahon D; Gordon A; Jacobs TP; Canfield RE
J Bone Miner Res; 1989 Feb; 4(1):75-9. PubMed ID: 2718781
[TBL] [Abstract][Full Text] [Related]
14. Serum osteocalcin concentrations in Paget's disease of bone.
Wilkinson MR; Wagstaffe C; Delbridge L; Wiseman J; Posen S
Arch Intern Med; 1986 Feb; 146(2):268-71. PubMed ID: 3484940
[TBL] [Abstract][Full Text] [Related]
15. Serum osteocalcin (BGP) in tumor-associated hypercalcemia.
Body JJ; Cleeren A; Pot M; Borkowski A
J Bone Miner Res; 1986 Dec; 1(6):523-7. PubMed ID: 3509743
[TBL] [Abstract][Full Text] [Related]
16. [Separation and purefied of calf osteocalcin, set up radioimmunoassay for osteocalcin].
Kong Y; Meng X; Zhou X; Liu H; Liu S
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Aug; 19(4):257-62. PubMed ID: 10453563
[TBL] [Abstract][Full Text] [Related]
17. Binding of serum osteocalcin to hydroxyapatite in Paget's disease of bone.
Torres R; de la Piedra C; Rapado A
Bone Miner; 1991 Jul; 14(1):55-65. PubMed ID: 1868269
[TBL] [Abstract][Full Text] [Related]
18. [Serum osteocalcin in hyperthyroidism].
Roiter I; Legovini P; Da Rin G; Galliazzo S; Di Virgilio R; Foscolo G; Breda F; Conte N
Ann Ital Med Int; 1990; 5(2):95-9. PubMed ID: 2248865
[TBL] [Abstract][Full Text] [Related]
19. Serum osteocalcin in Paget's disease of bone: basal concentrations and response to bisphosphonate treatment.
Papapoulos SE; Frolich M; Mudde AH; Harinck HI; vd Berg H; Bijvoet OL
J Clin Endocrinol Metab; 1987 Jul; 65(1):89-94. PubMed ID: 3495547
[TBL] [Abstract][Full Text] [Related]
20. Comparison of serum osteocalcin with total and bone specific alkaline phosphatase and urinary hydroxyproline:creatinine ratio in patients with Paget's disease of bone.
Kaddam IM; Iqbal SJ; Holland S; Wong M; Manning D
Ann Clin Biochem; 1994 Jul; 31 ( Pt 4)():327-30. PubMed ID: 7979096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
